Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?
Obesity is a major factor in contemporary clinical practice in nephrology. Obesity accelerates the progression of both diabetic and non-diabetic chronic kidney disease and, in renal transplantation, both recipient and donor obesity increase the risk of allograft complications. Obesity is thus a majo...
Main Authors: | William P. Martin, James White, Francisco J. López-Hernández, Neil G. Docherty, Carel W. le Roux |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2020.00289/full |
Similar Items
-
The Effect of Metabolic Surgery on the Complications of Diabetes: What Are the Unanswered Questions?
by: Karl J. Neff, et al.
Published: (2020-05-01) -
Retinopathy and Risk of Kidney Disease in Persons With DiabetesPlain-Language Summary
by: Jingyao Hong, et al.
Published: (2021-09-01) -
The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort
by: Matthew B. Palmer, et al.
Published: (2021-04-01) -
The Risk of Stroke in Kidney Transplant Recipients with End-Stage Kidney Disease
by: Shih-Ting Huang, et al.
Published: (2019-01-01) -
Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease
by: Yiting Wang, et al.
Published: (2021-07-01)